C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome
- PMID: 12144861
- DOI: 10.1016/s0006-8993(02)02920-7
C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome
Abstract
Following traumatic brain injury, the neuronally-localized intracellular protein MAP-tau is proteolytically cleaved (C-tau) and gains access to cerebrospinal fluid (CSF) and serum. The present study compared initial CSF C-tau levels, initial Glasgow Coma Scale (GCS) scores and elevated intracranial pressure (ICP) as predictors of clinical outcome. In this preliminary, prospective study of consecutive severe traumatic brain injured patients (TBI) clinical outcome was quantified with the Glasgow Outcome Scale (GOS) at discharge (n=28). Sensitivity and specificity of initial C-tau levels and initial GCS scores as predictors of clinical outcome is reported. To assess disease specificity C-tau levels were compared between TBI patients and neurologic (n=87) and non-neurologic control patients (n=67). Initial CSF C-tau levels were elevated 40,000 fold in TBI patients compared to either neurologic or non-neurologic control patients (P<0.001). Initial C-tau levels were correlated with clinical outcome (P=0.006) and were a significant predictor of dichotomized clinical outcome (P=0.011) demonstrating a sensitivity of prediction of 92% and a specificity of 94%. Initial C-tau levels were also a significant predictor of subsequent ICP with higher initial C-tau levels associated with elevated ICP (P=0.014). Initial GCS score were correlated with clinical outcome (P=0.026) and demonstrated a sensitivity of 50% and a specificity of 100% for predicting dichotomized clinical outcome. Statistical analysis indicated that initial C-tau levels and initial GCS scores were independent predictors of clinical outcome. The present preliminary study demonstrates that initial CSF C-tau levels are a significant predictor of ICP and clinical outcome with particular sensitivity for identifying severe TBI patients with good clinical outcome. Future studies employing a larger sample size and clinical outcome assessment at longer periods after hospitalization will be needed to determine the utility of initial C-tau levels as a clinical biomarker in TBI.
Similar articles
-
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure.J Neurotrauma. 2008 Feb;25(2):79-93. doi: 10.1089/neu.2007.0386. J Neurotrauma. 2008. PMID: 18260791
-
A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.Br J Neurosurg. 2017 Jun;31(3):356-363. doi: 10.1080/02688697.2017.1297378. Epub 2017 Mar 15. Br J Neurosurg. 2017. PMID: 28293977
-
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.Neurology. 2006 Nov 14;67(9):1600-4. doi: 10.1212/01.wnl.0000242732.06714.0f. Neurology. 2006. PMID: 17101890
-
Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.Crit Care Med. 2010 Jan;38(1):138-44. doi: 10.1097/CCM.0b013e3181b788ab. Crit Care Med. 2010. PMID: 19726976 Free PMC article.
-
[Value of serial CT scanning and intracranial pressure monitoring for detecting new intracranial mass effect in severe head injury patients showing lesions type I-II in the initial CT scan].Neurocirugia (Astur). 2005 Jun;16(3):217-34. Neurocirugia (Astur). 2005. PMID: 16007322 Review. Spanish.
Cited by 47 articles
-
Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria.Clin Infect Dis. 2020 Mar 3;70(6):1161-1168. doi: 10.1093/cid/ciz325. Clin Infect Dis. 2020. PMID: 31044219 Free PMC article.
-
Tau protein as a diagnostic marker for diffuse axonal injury.PLoS One. 2019 Mar 22;14(3):e0214381. doi: 10.1371/journal.pone.0214381. eCollection 2019. PLoS One. 2019. PMID: 30901365 Free PMC article. Clinical Trial.
-
Effects of concussion on the blood-brain barrier in humans and rodents.J Concussion. 2017 Jan-Dec;1:10.1177/2059700216684518. doi: 10.1177/2059700216684518. Epub 2017 Jan 1. J Concussion. 2017. PMID: 30828466 Free PMC article.
-
Kininogen Level in the Cerebrospinal Fluid May Be a Potential Biomarker for Predicting Epileptogenesis.Front Neurol. 2019 Jan 31;10:37. doi: 10.3389/fneur.2019.00037. eCollection 2019. Front Neurol. 2019. PMID: 30804871 Free PMC article.
-
Protein biomarkers of epileptogenicity after traumatic brain injury.Neurobiol Dis. 2019 Mar;123:59-68. doi: 10.1016/j.nbd.2018.07.017. Epub 2018 Jul 17. Neurobiol Dis. 2019. PMID: 30030023 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical